CIS - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingCIS: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024
Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in CIS
The CIS market for hormones, prostaglandins, thromboxanes and leukotrienes totaled $X in 2022, flattening at the previous year. The total consumption indicated resilient growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2020 indices. The level of consumption peaked at $X in 2020; afterwards, it flattened through to 2022.
Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in CIS
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production expanded modestly to $X in 2022 estimated in export price. The total production indicated buoyant growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The most prominent rate of growth was recorded in 2017 with an increase of X%. Over the period under review, production reached the maximum level at $X in 2020; afterwards, it flattened through to 2022.
Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Exports in CIS
In 2022, shipments abroad of hormones, prostaglandins, thromboxanes and leukotrienes was finally on the rise to reach X tons for the first time since 2019, thus ending a two-year declining trend. Overall, exports posted buoyant growth. The growth pace was the most rapid in 2017 when exports increased by X%. As a result, the exports attained the peak of X tons. From 2018 to 2022, the growth of the exports remained at a somewhat lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports skyrocketed to $X in 2022. Over the period under review, exports posted buoyant growth. The pace of growth appeared the most rapid in 2017 with an increase of X%. As a result, the exports attained the peak of $X. From 2018 to 2022, the growth of the exports failed to regain momentum.
Exports by Country
Kyrgyzstan represented the key exporting country with an export of around X tons, which finished at X% of total exports. Russia (X kg) held a X% share (based on physical terms) of total exports, which put it in second place, followed by Belarus (X%). Kazakhstan (X kg) took a little share of total exports.
Kyrgyzstan was also the fastest-growing in terms of the hormones, prostaglandins, thromboxanes and leukotrienes exports, with a CAGR of X% from 2012 to 2022. Belarus (X%), Russia (X%) and Kazakhstan (X%) illustrated a downward trend over the same period. Kyrgyzstan (X p.p.) significantly strengthened its position in terms of the total exports, while Belarus, Kazakhstan and Russia saw its share reduced by X%, X% and X% from 2012 to 2022, respectively.
In value terms, Kyrgyzstan ($X) remains the largest hormones, prostaglandins, thromboxanes and leukotrienes supplier in the CIS, comprising X% of total exports. The second position in the ranking was held by Belarus ($X), with a X% share of total exports. It was followed by Russia, with a X% share.
In Kyrgyzstan, hormones, prostaglandins, thromboxanes and leukotrienes exports increased at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Belarus (X% per year) and Russia (X% per year).
Export Prices by Country
The export price in the CIS stood at $X per kg in 2022, with a decrease of X% against the previous year. In general, the export price showed a pronounced decline. The most prominent rate of growth was recorded in 2018 when the export price increased by X% against the previous year. The level of export peaked at $X per kg in 2012; however, from 2013 to 2022, the export prices stood at a somewhat lower figure.
There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Kyrgyzstan ($X per kg), while Russia ($X per kg) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kyrgyzstan (X%), while the other leaders experienced a decline in the export price figures.
Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Imports in CIS
In 2022, hormones, prostaglandins, thromboxanes and leukotrienes imports in the CIS dropped rapidly to X tons, with a decrease of X% compared with 2021. In general, imports saw a perceptible descent. The most prominent rate of growth was recorded in 2016 when imports increased by X%. Over the period under review, imports reached the peak figure at X tons in 2018; however, from 2019 to 2022, imports failed to regain momentum.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports fell dramatically to $X in 2022. Overall, imports, however, recorded prominent growth. The growth pace was the most rapid in 2013 with an increase of X% against the previous year. Over the period under review, imports hit record highs at $X in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.
Imports by Country
Russia prevails in imports structure, reaching X tons, which was approx. X% of total imports in 2022. It was distantly followed by Belarus (X tons), generating a X% share of total imports. Kazakhstan (X kg) took a minor share of total imports.
Russia was also the fastest-growing in terms of the hormones, prostaglandins, thromboxanes and leukotrienes imports, with a CAGR of X% from 2012 to 2022. At the same time, Kazakhstan (X%) displayed positive paces of growth. By contrast, Belarus (X%) illustrated a downward trend over the same period. While the share of Russia (X p.p.) and Kazakhstan (X p.p.) increased significantly in terms of the total imports from 2012-2022, the share of Belarus (X p.p.) displayed negative dynamics.
In value terms, Russia ($X) constitutes the largest market for imported hormones, prostaglandins, thromboxanes and leukotrienes in the CIS, comprising X% of total imports. The second position in the ranking was taken by Kazakhstan ($X), with a X% share of total imports.
In Russia, hormones, prostaglandins, thromboxanes and leukotrienes imports expanded at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Kazakhstan (X% per year) and Belarus (X% per year).
Import Prices by Country
In 2022, the import price in the CIS amounted to $X per kg, declining by X% against the previous year. Overall, the import price, however, showed significant growth. The growth pace was the most rapid in 2013 an increase of X% against the previous year. Over the period under review, import prices reached the peak figure at $X per kg in 2019; however, from 2020 to 2022, import prices stood at a somewhat lower figure.
Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Russia ($X per kg), while Belarus ($X per kg) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Belarus (X%), while the other leaders experienced mixed trends in the import price figures.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in CIS. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21105200 - Hormones, prostaglandins, thromboxanes and leukotrienes, n atural or reproduced by synthesis, derivatives and structural analogues thereof, including chain modified polypeptides, u sed primarily as hormones
Country coverage:
- Armenia
- Azerbaijan
- Belarus
- Kazakhstan
- Kyrgyzstan
- Moldova
- Russia
- Tajikistan
- Uzbekistan
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in CIS, split by region and country
- Trade (exports and imports) in CIS
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Armenia
- Azerbaijan
- Belarus
- Kazakhstan
- Kyrgyzstan
- Moldova
- Russia
- Tajikistan
- Uzbekistan
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Asia.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the U.S..
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in China.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the EU.
This report provides an in-depth analysis of the global market for hormones, prostaglandins, thromboxanes and leukotrienes.